J&J to Acquire Vaccine Maker Crucell

Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Continue reading J&J to Ac…

Johnson & Johnson Plans to Buy Vaccine Maker Crucell

Still in hot water over its “phantom recall” of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Continue reading Johnson & …